• John G. BartlettBartlett on HIV/AIDS
    Recent Hot Information About Abacavir  Watch as Dr. John G. Bartlett reviews recent abstracts, publications, commentary, industry response, and DHHS and NIAID communication and bulletin regarding the efficacy and risk of MI with abacavir.
 

HIV/AIDS News

From Medscape Medical News, TheHeart.org, Reuters and more
  • No content available.
  • No content available.
 
 
 
 
 
 
 
 
 
 
 
 
 

POLL

A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?
Would significantly reduce bias
Would somewhat reduce bias
Would not reduce bias
Uncertain
My prescribing decisions are not influenced by drug company representatives
Related Link: Senate press release
 
 
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.